Search Results for: USP2

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
HOMER3 homer scaffold protein 3
  • Neurexins and neuroligins
  • Neurexins and neuroligins
HOOK1 hook microtubule tethering protein 1
HOOK2 hook microtubule tethering protein 2
IHO1 interactor of HORMAD1 1
IKBKG inhibitor of nuclear factor kappa B kinase regulatory subunit gamma
  • Activation of NF-kappaB in B cells
  • Activation of NF-kappaB in B cells
  • ER-Phagosome pathway
  • NOD1/2 Signaling Pathway
  • TICAM1, RIP1-mediated IKK complex recruitment
  • RIP-mediated NFkB activation via ZBP1
  • Downstream TCR signaling
  • FCERI mediated NF-kB activation
  • TAK1-dependent IKK and NF-kappa-B activation
  • activated TAK1 mediates p38 MAPK activation
  • JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1
  • SUMOylation of immune response proteins
  • Regulation of TNFR1 signaling
  • TNFR1-induced NF-kappa-B signaling pathway
  • IKBKB deficiency causes SCID
  • IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR)
  • IkBA variant leads to EDA-ID
  • CLEC7A (Dectin-1) signaling
  • MAP3K8 (TPL2)-dependent MAPK1/3 activation
  • Ub-specific processing proteases
  • Ovarian tumor domain proteases
  • Interleukin-1 signaling
  • TRAF6 mediated NF-kB activation
  • NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10
  • IRAK1 recruits IKK complex
  • IKK complex recruitment mediated by RIP1
  • SARS-CoV-2 activates/modulates innate and adaptive immune responses
  • IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation
  • Regulation of NF-kappa B signaling
  • PKR-mediated signaling
  • SLC15A4:TASL-dependent IRF5 activation
  • Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells
  • Modulation of host responses by IFN-stimulated genes
  • AGRO100
  • Tarenflurbil
  • Incontinentia pigmenti
  • Ectodermal dysplasia associated immunodeficiency (EDA-ID), including the following two diseases: NF-kappa-B essential modulator (NEMO) defect; Inhibitor of kappa-B (I-kappa-B) defect
  • Osteoporosis, lymphedema, anhydrotic ectodermal dysplasia with immunodeficiency (OLEDAID); Ectodermal dysplasia, anhidrotic, with immunodeficiency, osteopetrosis, and lymphedema
IKZF3 IKAROS family zinc finger 3
IL1RL2 interleukin 1 receptor like 2
  • Interleukin-38 signaling
  • Interleukin-36 pathway
  • Spesolimab
INTS11 integrator complex subunit 11
  • RNA polymerase II transcribes snRNA genes
  • RNA polymerase II transcribes snRNA genes
JAKMIP1 janus kinase and microtubule interacting protein 1
JRK Jrk helix-turn-helix protein
KAZN kazrin, periplakin interacting protein
  • Formation of the cornified envelope
KIFC3 kinesin family member C3
KRT15 keratin 15
  • Keratinization
  • Formation of the cornified envelope
  • Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin
KRT27 keratin 27
  • Keratinization
  • Formation of the cornified envelope
KRT31 keratin 31
  • Keratinization
  • Formation of the cornified envelope
KRT33B keratin 33B
  • Keratinization
  • Formation of the cornified envelope
KRT34 keratin 34
  • Keratinization
  • Formation of the cornified envelope
KRT35 keratin 35
  • Keratinization
  • Formation of the cornified envelope
KRT40 keratin 40
  • Keratinization
  • Formation of the cornified envelope
LHX3 LIM homeobox 3
  • Regulation of expression of SLITs and ROBOs
  • Pituitary Dwarfism (PD); Isolated growth hormone deficiency (IGHD); Short Stature and Pituitary Defects (SSPD); Insulin-like growth factor 1 deficiency (IGFD)

Page 4 out of 9 pages